Skip to Content

R 626 (Zafirlukast 20 mg)

Pill with imprint R 626 is Pink, Round and has been identified as Zafirlukast 20 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Zafirlukast is used in the treatment of asthma, maintenance and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Zafirlukast 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R 626

Zafirlukast

Imprint:
R 626
Strength:
20 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients:
hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0059 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide